Roshawn A. Blunt's Insider Trades & SAST Disclosures

Roshawn A. Blunt's most recent trade in Kronos Bio Inc was a trade of 41,200 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.

Share

Note

This is a custom search result for pattern Roshawn A. Blunt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Kronos Bio Inc	Roshawn A. Blunt	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2025	41,200	0	-		-	Stock Option (Right to Buy)
Kronos Bio Inc	Roshawn A. Blunt	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2025	34,000	0	-		-	Stock Option (Right to Buy)
Kronos Bio Inc	Roshawn A. Blunt	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2025	34,000	0	-		-	Stock Option (Right to Buy)
Kronos Bio Inc	Roshawn A. Blunt	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2025	34,000	0	-		-	Stock Option (Right to Buy)
Kronos Bio Inc	Roshawn A. Blunt	Director		25 Jun 2024	34,000	34,000	-		-	Stock Option (Right to Buy)
Kronos Bio Inc	Roshawn A. Blunt	Director		22 Jun 2023	34,000	34,000	-		-	Stock Option (Right to Buy)
Reneo Pharmaceuticals Inc Results	Roshawn A. Blunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2023	14,815	14,815	-		-	Stock Option (right to buy)
Reneo Pharmaceuticals Inc Results	Roshawn A. Blunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Aug 2022	35,000	35,000	-		-	Stock Option (right to buy)
Kronos Bio Inc	Roshawn A. Blunt	Director		22 Jun 2022	34,000	34,000	-		-	Stock Option (Right to Buy)
Kronos Bio Inc	Roshawn A. Blunt	Director		11 Nov 2021	41,200	41,200	-		-	Director Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades